Brief: Olema Pharmaceuticals Inc - Terminates ATM Prospectus For Common Stock Dated January 6, 2025 - SEC Filing
18/11/2025 21:55
Nov 18 (Reuters) - Olema Pharmaceuticals Inc OLMA.O: OLEMA PHARMACEUTICALS INC - TERMINATES ATM PROSPECTUS FOR COMMON STOCK DATED JANUARY 6, 2025 - SEC FILING Further company coverage: OLMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Olema Pharmaceuticals
See all newsOlema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Olema Pharmaceuticals Q2 net loss widens on higher clinical trial spending
Brief: Olema Pharmaceuticals Q2 Net Income USD -63.2 Million
Brief: Olema Oncology Announces Clinical Trial Collaboration And Supply Agreement With Bayer To Evaluate Op-3136 In Combination With Nubeqa® (Darolutamide) In Metastatic Castration-Resistant Prostate Cancer
Olema Pharmaceuticals Q1 net loss widens on higher R&D costs